MINTZ LIAT has a total of 34 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are BULLERDIEK JOERN, STEMRIM INC and LU LICENSE AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | Australia | 4 | |
#6 | Republic of Korea | 3 | |
#7 | Brazil | 2 | |
#8 | Hong Kong | 1 | |
#9 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Machines | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes | |
#5 | Microorganisms | |
#6 | Enzymes | |
#7 | Unspecified technologies | |
#8 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Mintz Liat | 34 |
#2 | Chen Aviva | 1 |
#3 | Eshel Dani | 1 |
#4 | Toporik Amir | 1 |
#5 | Bernstein Jeanne | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015017123A1 | Ghrelin splice variant for treating neuronal damage,neurodegenerative disease, parkinsons disease, alzheimers disease, and/or depression | |
US2009043074A1 | Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation | |
US2011245161A1 | Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia | |
KR20080113406A | Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation | |
CA2626831A1 | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance | |
AU2004273053A1 | Ghrelin variant protein |